Suppr超能文献

多核细胞利用 ROS 在体内和体外诱导乳腺癌的化疗耐药性。

Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.

机构信息

School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, 721302, India.

Department of Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, 721302, India.

出版信息

Oncogene. 2018 Aug;37(33):4546-4561. doi: 10.1038/s41388-018-0272-6. Epub 2018 May 10.

Abstract

Although there is a strong correlation between multinucleated cells (MNCs) and cancer chemo-resistance in variety of cancers, our understanding of how multinucleated cells modulate the tumor micro-environment is limited. We captured multinucleated cells from triple-negative chemo-resistant breast cancers cells in a time frame, where they do not proliferate but rather significantly regulate their micro-environment. We show that oxidatively stressed MNCs induce chemo-resistance in vitro and in vivo by secreting VEGF and MIF. These factors act through the RAS/MAPK pathway to induce chemo-resistance by upregulating anti-apoptotic proteins. In MNCs, elevated reactive oxygen species (ROS) stabilizes HIF-1α contributing to increase production of VEGF and MIF. Together the data indicate, that the ROS-HIF-1α signaling axis is very crucial in regulation of chemo-resistance by MNCs. Targeting ROS-HIF-1α in future may help to abrogate drug resistance in breast cancer.

摘要

虽然在多种癌症中多核细胞(MNCs)与癌症化疗耐药性之间存在很强的相关性,但我们对多核细胞如何调节肿瘤微环境的理解是有限的。我们在一个时间范围内从三阴性化疗耐药性乳腺癌细胞中捕获多核细胞,此时它们不会增殖,而是显著调节其微环境。我们表明,氧化应激的多核细胞通过分泌 VEGF 和 MIF 在体外和体内诱导化疗耐药性。这些因子通过 RAS/MAPK 途径作用,通过上调抗凋亡蛋白诱导化疗耐药性。在多核细胞中,升高的活性氧(ROS)稳定 HIF-1α,有助于增加 VEGF 和 MIF 的产生。总之,数据表明,ROS-HIF-1α信号轴在多核细胞调节化疗耐药性中非常关键。未来靶向 ROS-HIF-1α 可能有助于消除乳腺癌的耐药性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验